-
Non Regulatory April 12, 2021Oasmia Presents Cantrixil Final Phase I Data at the 2021 AACR Annual Meeting
-
Non Regulatory April 1, 2021Oasmia Pharmaceutical Appoints Dr Reinhard Koenig as Chief Scientific Officer
-
Non Regulatory March 26, 2021Oasmia to Present Cantrixil Final Phase I Data at the 2021 AACR Virtual Annual Meeting
Oasmia Pharmaceutical published its Year-end report for the shortened financial year May 1, 2020 – December 31, 2020 on February 19, 2021, at 08.00 am CET. The company held a conference call and an online presentation on the same day at 10.00 am CET.
Oasmia and Elevar sign a global strategic partnership for the commercialization of Apealea®